CDKN2A and Miyoshi myopathy: Another study found that mutations in genes linked to the cell cycle were prevalent, with amplifications in CDK4 and CCND1 present in 47.0% and 27.7% of samples, respectively, while P16INK4a was deleted in 57.7% of MM cases.